Skip to main content

WELLS FARGO & COMPANY/MN

Position in ACRV — Acrivon Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in ACRV

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$4,170
+$4,003 QoQ
Shares Held
3,000
+2027.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACRV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ACRV

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,170 3,000
2025-06-30 $167 141
2025-03-31 $14,392 7,090
2024-12-31 $41,736 6,933
2024-09-30 $37,954 5,422
2024-06-30 $30,107 5,191
2024-03-31 $30,737 4,299
2023-12-31 $13,239 2,691
2023-09-30 $20,659 2,161
2023-06-30 $42,832 3,305
2023-03-31 $20,151 1,588